Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC. Du C, Chen Y, Zhou Y, Zheng D, et al. BMC Cancer 2023;23:1260.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Du C, Chen Y, Zhou Y, Zheng D, et al. Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC. BMC Cancer 2023;23:1260.
PMID: 38129808